IGG4 RELATED DISEASE
Clinical trials for IGG4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to stop Flare-Ups in rare autoimmune disease
Disease control OngoingThis study tests a drug called inebilizumab to see if it can prevent flare-ups in people with IgG4-related disease, a rare condition where the immune system attacks the body. About 135 adults who have had recent flare-ups are taking part. The main goal is to see how long it takes…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug aims to stop Flare-Ups in rare autoimmune disease
Disease control OngoingThis study tests a drug called obexelimab to see if it can prevent flare-ups in people with IgG4-related disease, a rare condition where the immune system attacks the body. About 194 adults with active disease will receive either the drug or a placebo. The main goal is to measure…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC